Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases

Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences